Roivant Sciences Stock Z Score
| ROIV Stock | USD 10.90 0.04 0.37% |
Roivant | Z Score |
Roivant Sciences Company Z Score Analysis
Roivant Sciences' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..
| |||||||
| |||||||
| |||||||
| |||||||
|
Roivant Z Score Driver Correlations
Understanding the fundamental principles of building solid financial models for Roivant Sciences is extremely important. It helps to project a fair market value of Roivant Stock properly, considering its historical fundamentals such as Z Score. Since Roivant Sciences' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Roivant Sciences' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Roivant Sciences' interrelated accounts and indicators.
Click cells to compare fundamentals
To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.
| Competition |
Based on the company's disclosures, Roivant Sciences has a Z Score of 0.0. This is 100.0% lower than that of the Biotechnology sector and 100.0% lower than that of the Health Care industry. The z score for all United States stocks is 100.0% higher than that of the company.
Roivant Sciences Current Valuation Drivers
We derive many important indicators used in calculating different scores of Roivant Sciences from analyzing Roivant Sciences' financial statements. These drivers represent accounts that assess Roivant Sciences' ability to generate profits relative to its revenue, operating costs, and shareholders' equity. Below are some of Roivant Sciences' important valuation drivers and their relationship over time.
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Enterprise Value | 235.1M | 367.6M | 1.5B | 4.1B | 3.7B | 3.8B |
Roivant Sciences Institutional Holders
Institutional Holdings refers to the ownership stake in Roivant Sciences that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Roivant Sciences' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Roivant Sciences' value.| Shares | Baker Bros Advisors Lp | 2023-12-31 | 7.6 M | Farallon Capital Management, L.l.c. | 2023-12-31 | 7.3 M | Vanguard Group Inc | 2023-12-31 | 7.1 M | Woodline Partners Lp | 2023-12-31 | 6.2 M | Geode Capital Management, Llc | 2023-12-31 | 5.5 M | Adage Capital Partners Gp Llc | 2023-12-31 | 5.3 M | Anchorage Advisors, Llc | 2023-12-31 | 4.8 M | Venbio Select Advisor Llc | 2023-12-31 | 4.7 M | Octagon Capital Advisors Lp | 2023-09-30 | 4.4 M | Qvt Financial Lp | 2023-12-31 | 112.5 M | Sb Investment Advisers (uk) Ltd | 2023-12-31 | 73 M |
Roivant Fundamentals
| Return On Equity | 1.06 | ||||
| Return On Asset | -0.14 | ||||
| Profit Margin | 36.24 % | ||||
| Operating Margin | (7.74) % | ||||
| Current Valuation | 2.87 B | ||||
| Shares Outstanding | 805.85 M | ||||
| Shares Owned By Insiders | 20.63 % | ||||
| Shares Owned By Institutions | 62.14 % | ||||
| Number Of Shares Shorted | 30.93 M | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 71.53 X | ||||
| Revenue | 61.28 M | ||||
| Gross Profit | (477.06 M) | ||||
| EBITDA | (1.11 B) | ||||
| Net Income | (1.12 B) | ||||
| Cash And Equivalents | 1.94 B | ||||
| Cash Per Share | 2.76 X | ||||
| Total Debt | 481.4 M | ||||
| Debt To Equity | 0.28 % | ||||
| Current Ratio | 6.20 X | ||||
| Book Value Per Share | 7.57 X | ||||
| Cash Flow From Operations | (843.39 M) | ||||
| Short Ratio | 3.39 X | ||||
| Earnings Per Share | 5.27 X | ||||
| Target Price | 15.9 | ||||
| Number Of Employees | 904 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 8.82 B | ||||
| Total Asset | 2.39 B | ||||
| Retained Earnings | (3.77 B) | ||||
| Working Capital | 1.53 B | ||||
| Net Asset | 2.39 B |
About Roivant Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Roivant Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Roivant Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Roivant Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
When determining whether Roivant Sciences is a strong investment it is important to analyze Roivant Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Roivant Sciences' future performance. For an informed investment choice regarding Roivant Stock, refer to the following important reports:Check out Roivant Sciences Piotroski F Score and Roivant Sciences Valuation analysis. For more information on how to buy Roivant Stock please use our How to Invest in Roivant Sciences guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Complementary Tools for Roivant Stock analysis
When running Roivant Sciences' price analysis, check to measure Roivant Sciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Roivant Sciences is operating at the current time. Most of Roivant Sciences' value examination focuses on studying past and present price action to predict the probability of Roivant Sciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Roivant Sciences' price. Additionally, you may evaluate how the addition of Roivant Sciences to your portfolios can decrease your overall portfolio volatility.
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |
Is Roivant Sciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Roivant Sciences. If investors know Roivant will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Roivant Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share 5.27 | Revenue Per Share 0.16 | Quarterly Revenue Growth 1.178 | Return On Assets (0.14) | Return On Equity 1.058 |
The market value of Roivant Sciences is measured differently than its book value, which is the value of Roivant that is recorded on the company's balance sheet. Investors also form their own opinion of Roivant Sciences' value that differs from its market value or its book value, called intrinsic value, which is Roivant Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Roivant Sciences' market value can be influenced by many factors that don't directly affect Roivant Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Roivant Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Roivant Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Roivant Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.